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Abstract: ACTIVATION OF CYSTIC FIBROSIS MACROPHAGES IS
DYSREGULATED
Evan J. Levy, Cristina Barone, Emanuela Bruscia, Marie E. Egan. Department of
Pediatrics, Yale University School of Medicine, New Haven, CT.
We hypothesize that intrinsic defects in cystic fibrosis (CF) macrophages
affect their ability to adequately respond to extracellular stimuli, affecting their
phenotypic response and contributing to a hyper-inflammatory state.
Peripheral blood-derived monocytes from healthy donors (HD) (n=10) as
well as CF subjects (n=10) were differentiated into macrophages using RPMI
media with 50 ng/mL of MCSF for 10 days. Cells were treated with 100 ng/mL of
LPS plus 20 ng/mL of INF-gamma to activate the M1 phenotype or 20 ng/mL of
IL-4 to activate the M2 phenotype. Cells were treated for 24 hours in preparation
for RNA isolation and 3 hours in preparation for protein isolation. RNA was
isolated and reverse transcribed to cDNA in preparation for qualitative, reverse
transcription polymerase chain reaction (qRT-PCR). qRT-PCR was performed
using IL-6, IL-1B, and TNF-alpha primers as M1 markers and TGF-B1, MRC,
PPAR-gamma as M2 markers. Expression levels were performed in seven
experiments, each using a different set of HD and CF subjects, utilizing 8.0 x
10^5 to 1.0 x 10^6 cells per well, while three protein experiment were done using
different sets of HD and CF subjects.
Stimulation of CF macrophages induces greater phosphorylation of
proteins that regulate macrophage activation, as compared to HD macrophages.
When CF macrophages are challenged with LPS/INF-gamma, they show greater
phosphorylation of STAT1 protein as compared to HD macrophages. Similarly,
when CF macrophages are challenged with IL-4, they exhibit greater
phosphorylation of STAT6 protein, as compared to HD macrophages. Finally, CF
macrophages show greater phosphorylation of AKT protein as compared to HD
macrophages when stimulated with both M1 and M2 cytokines. As expected, HD
macrophages (n=7, experiments) demonstrated appropriate plasticity and
polarization with increased expression of M1 markers and decreased expression
of M2 markers in response to LPS/INF-gamma. Furthermore, they demonstrated
modestly increased expression of M2 markers and decreased expression of M1
markers in response to IL-4. In marked contrast, when stimulated with LPS/INFgamma CF macrophages (n=7, experiments) demonstrated hyper-inflammation
with dramatically increased expression levels of M1 markers as well as aberrant
polarization as evidenced by increased expression levels of some M2 makers.
Aberrant polarization was further characterized by increased expression of M1
markers in the presence of IL-4 in addition to increased expression of M2
markers.
These data suggest that lack of functioning CFTR in macrophages leads
to the inability of macrophages to adequately respond to environmental cues and
activate into appropriate phenotypes suggesting there is an intrinsic cellular
defect. Moreover, the mechanism(s) that underlie these aberrant responses likely
involve altered intracellular signal transduction which is currently under
investigation.
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1. Introduction

1.1 Cystic Fibrosis
Cystic Fibrosis (CF) is an autosomal recessive disease caused by a mutation
to the gene that codes for the cystic fibrosis transmembrane conductance
regulator (CFTR) protein. The disease manifests as a chronic, degenerative
process that affects the upper and lower respiratory tracts, the pancreas, the
hepatobiliary tree, intestinal tract, sweat glands and the reproductive tracts [1].

1-1.1 Clinical Diagnosis
As of 2015, 59.6% of patients are diagnosed through newborn screening
(NBS) by measuring for uncharacteristically high levels of immunoreactive
trypsinogen (IRT) in blood spot tests [2]. High levels of IRT indicate pancreatic
damage. High levels are not specific to CF, and infants that screen positive for
IRT require either further genetic testing or confirmation with a sweat chloride
test. Classically, a diagnosis of cystic fibrosis is made when clinical features of
the disease accompany a sweat chloride concentration greater than 60 mmol/L.
If sweat chloride concentrations fall in the intermediate range of 30-59 mmol/L,
further DNA testing can be done [3]. NBS and early diagnosis are important, as
early intervention allows for improved nutrition and growth, which may play an
important role in reducing disease burden. In fact, several studies have shown a
correlation between improved growth rates in infancy/childhood and improved
lung function later into adolescence [4, 5].
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1-1.2 Clinical Presentation
CF often presents as a classical clinical sequelae of homozygous
mutations within Class I-III categorizations. The neonatal period is often
significant for meconium ileus, protracted jaundice, and intestinal atresia. In
infancy, CF patients begin to experience failure to thrive and chronic diarrhea
from pancreatic insufficiency; cholestasis, chronic infection with Staphylococcus
aureus (Sa), and anemia also present. In the absence of NBS or sweat chloride
testing, infants with CF can go undiagnosed, further exacerbating these
manifestations. Some pathognomonic features of CF in childhood include rectal
prolapse, intussusception, distal intestinal obstruction syndrome (DIOS), chronic
pansinusitis or nasal polyposis, ABPA, and the beginning of liver disease. In
adulthood, CF manifests as advanced lung disease often requiring transplant
after 30 years of age, chronic infection with Pseudomonas aeruginosa (Pa), CF
related diabetes (CFRD), anxiety, osteopenia, congenital bilateral absence of vas
deferens in mails, digestive tract cancer, and advanced liver disease ([1, 3]). Due
to the great strides made in drug development and in clinical management, more
than 50% of CF patients are adults with the median predicted survival age up to
41.6 years, up from around 30 years in 1987 ([2]). As a result, our understanding
of the adult disease sequelae is evolving.
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1-1.3 Genetic Basis of Disease
The gene coding the CFTR protein was identified in 1989 and was
localized to chromosome 7 ([6]). To date, over 1500 mutations have been
identified, but the functional importance of only several mutations is understood.
The deletion of the amino acid phenylalanine at position 508 on the CFTR protein
(F508del) is the most common allelic mutation, with an estimated frequency of
66% that varies within populations depending on demographics. While mutations
in the CFTR gene are the principal cause of disease in patients with CF, even
among patients who share the same genotype on each allele, there is great
variability of both clinical phenotype as well as survival outcomes. This variability
suggests that other environmental and genetic factors modify disease severity. In
fact, this variability can be partially explained by the presence of additional
genetic polymorphisms, such as -509 and codon 10 genotype variants of the 5’
end of TGFβ1, which further adversely modify disease phenotype [7].

1-1.4 CFTR Protein
Mutations in the CFTR gene lead to alterations in the synthesis, trafficking,
and function of the CFTR protein, a selective anion channel for chloride,
bicarbonate, and thiocyanate, that belongs to the adenine nucleotide-binding
cassette (ABC) protein family. The protein contains five domains: two nucleotidebinding domains (NBDs), two transmembrane domains, and a unique R domain.
Activation of the CFTR protein involves cAMP-dependent phosphorylation of the
R domain by PKA first, followed by binding and hydrolysis of ATP by the two
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NBDs to induce open and closed conformational changes. The two
transmembrane domains line the pore and regulate the conductance and
selectivity of the pore, allowing trafficking of anions down their electrochemical
gradient [6, 8]. This characteristic distinguishes the CFTR protein from other ABC
transporters, as the other members of this protein family utilize ATP hydrolysis to
transport ions up their electrochemical gradient.
Distinct CFTR mutations affect protein function differently and can be
further categorized into five classes. Class I mutations lead to defective synthesis
of the protein, Class II mutations lead to defective processing/protein maturation,
Class III mutations lead to defective protein regulation, Class IV mutations lead to
defective ion conductance, and Class V mutations lead reduced synthesis and
function [1].. As stated before, association between genotype and phenotype is
incomplete as twins may display varying phenotypes, but generally speaking,
severity of disease increases with ascending order of class mutation.

1-1.5 CFTR Role in Ion Transport
The CFTR protein is most commonly found on the apical membrane of
epithelial cells in the airways, exocrine pancreas, gastrointestinal tract, and sweat
ducts, where it is responsible for anion conductance, as well as regulation of
other ion channels. This widespread distribution of protein expression explains
the broad spectrum of clinical pathology, across numerous organ systems.
CFTR regulates salt and water transport across epithelial membranes, and loss
of function has been observed to cause decreased secretion of chloride and
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bicarbonate, as well as the increased transmembrane absorption of sodium.
Phosphorylation of the R domain activates the CFTR protein, opening the
channel for conductance to chloride and bicarbonate secretion, which in turn
creates an electrochemical driving force for parallel, paracellular diffusion of
sodium and water. This mechanism for secreting fluid is physiologically vital for
maintaining adequate airway surface liquid (ASL) and delivering exocrine
pancreatic and antimicrobial macromolecules to luminal surfaces [9, 10].

1-1.6 Pathophysiology of Dysfunctional Ion Transport
While the clinical manifestations of CF are diverse, around 80% of cysticfibrosis-related deaths are attributable to lung disease and pulmonary
insufficiency [1]. The three hallmarks of airway disease pathophysiology in CF
are chronic infection, dysregulated hyperinflammation, and airway obstruction.
This pathophysiology causes lung remodeling in the form of bronchiectasis that
leads to air trapping, hypercarbia, hypoxemia, and ultimately pulmonary
insufficiency. Although we know that loss of CFTR function leads to this
pathophysiology, and restoration of CFTR function corrects the underlying
pathobiology that drives disease, we still have a limited understanding of the
direct links between CFTR gene mutation and the pathophysiology of the
disease.
Several hypotheses have been proposed that link dysfunctional ion
transport with abnormalities in ASL that lead to thickened mucus and defective
mucociliary transport (MCT). These hypotheses propose that defective MCT and
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thickened mucus create environments that lead to chronic infections,
hyperinflammation, and ultimately the clinical manifestations of CF.

1-1.6.1 Abnormal ASL
ASL consists of an interface between a mucus layer and a periciliary liquid
layer (PCL). The mucus layer is responsible for trapping inhaled particles in
carbohydrate-rich mucins [11]. The PCL is responsible for keeping cilia fully
extended so that they can effectively beat and drive MCT. ASL volume is tightly
regulated in order to maintain PCL height and mucous viscosity in optimal
ranges. Boucher and colleagues propose that dysfunctional CFTR leads to a
dehydrated ASL that osmotically drives water out of both the PCL and mucous
layer. As a result, mucous viscosity increases with an increase in mucin
concentration, and PCL levels fall below the height necessary to keep cilia fully
extended and properly beating ([12, 13])

1-1.6.2 Dehydration Hypothesis
The “dehydration hypothesis” proposes that under physiologic conditions,
airway epithelial cells regulate ASL volume through the coordination of luminal
epithelial Na+ channel (ENaC) and CFTR. When ASL volume is high, increase
absorption of luminal sodium via ENaC transport leads to increased transcellular
H2O transport and paracellular Cl- transport from the lumen, resulting in
increased absorption of ASL fluid. Conversely, when ASL volume is low, CFTR
mediated Cl- secretion increases, which results in increased transcellular H2O
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secretion and paracellular Na+ secretion into the lumen, resulting in increased
secretion of ASL fluid. Overall, these counterbalancing processes lead to isotonic
fluid transport [10, 11].
Dysfunctional CFTR disrupts the equilibrium, as CFTR-mediated ASL
secretion decreases, and ENaC-mediated ASL absorption increases. This
imbalance leads to a dehydration of ASL, decreasing PCL height and increasing
mucus

viscosity

[14].

Mucus

plaques

develop

and

create

hypoxic

microenvironments that serve as breeding grounds for bacteria as defective MCT
greatly hinders clearance. In this setting, the dehydrated airway leads to chronic
infection as bacteria like Pa infiltrate the plaques, multiplying in nutrient rich
hypoxic environments, eventually adhering to the epithelial cells as biofilms.
Chronic infection provokes a hyperinflammatory response that can lead to lung
remodeling, airway obstruction and pulmonary insufficiency ([11-13, 15]).

1-1.6.3 High Salt Hypothesis
The “high salt hypothesis” argues that defects in CFTR impair transcellular
absorption of Cl- and ultimately lead to inability of epithelial cells to absorb salt.
Consequently, ion concentration of ASL fluid increases, while volume remains
unchanged [16]. Additionally, because CFTR regulates the secretion of
bicarbonate into the lumen, loss of CFTR function greatly decreases ASL fluid pH
[17].
Welsh and colleagues found that the ASL fluid recovered from CF
epithelia cells in culture displayed decreased bacterial killing in comparison to
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WT cells. The ASL fluid of CF epithelia cells had higher concentrations of salt
than WT cells, and when the fluid was diluted, the bactericidal properties were
restored [18]. Furthermore, they found that when CFTR function was restored to
epithelia cells, they were able to correct the high salt concentration of the ASL
fluid, and restore bacterial killing properties [19].
These findings supported the concept that ASL fluid must contain antimicrobial molecules that are essential for host defense. In the absence of
functional CFTR, the ASL becomes more acidic and highly concentrated with
salt, which in turn neutralizes the antimicrobial molecules [17]. This work led to
the discovery of specific molecules, such as human β-defensins and LL-37 that
are found in the ASL, and that exhibit gram-negative, antimicrobial properties.
These molecules are sensitive to both pH and salt concentration, and as a result,
become less effective in ASL fluid produced by CF epithelia cells in comparison
to WT cells [20, 21]. Finally, some studies have shown that decreased
bicarbonate secretion that results from loss of CFTR function, can also directly
affect the viscosity of the mucus layer in ASL fluid by preventing physiology
expansion and rheology of mucinous proteins [22]. In conclusion, as a result of
decreased pH and increased salt concentration, the ASL fluid of the CFTR
deficient airway exhibits reduced bactericidal properties and thickened mucus
viscosity that allows bacteria to chronically colonize the airways. This defect may
be the inciting event that leads to the pathogenesis of CF lung disease.
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1.2 Hyperinflammation in CF
1-2.1 CFTR Directly Causes Dysregulated Hyperinflammation
The CFTR protein acts principally as an anion channel. Therefore, it
comes as no surprise that significant resources have been focused on
elucidating

the

connections

between

abnormal

ion

transport

and

the

pathogenesis of CF. Most of these connections assert that chronic inflammation
is a secondary consequence that results when loss of CFTR function leaves the
CF airway vulnerable to chronic infections. Nevertheless, a growing body of
evidence supports the hypothesis that dysfunctional CFTR directly causes
hyperinflammation, even in the absence of infection [23].

1-2.2 Inflammation in the Absence of Infection
This paradigm shift is supported by experiments that show abnormally
increased levels of the pro-inflammatory mediator IL-8 as well as increased
numbers of monocytes and immune cells in CF ex-vivo, uninfected human fetal
tracheas cells [24]. Further studies examining the bronchoalveolar lavage fluid
(BALF) of infants without evidence of infection showed increased levels of proinflammatory mediators TNF-α, IL-1β, and IL-8 [25, 26]. Therefore, even in the
absence of pathogenic bacteria and clinically observable disease, CF airways
display

hyperinflammatory

phenotypes.

These

findings

hyperinflammation directly results from loss of CFTR function.

indicate
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1-2.3 Exaggerated, Persistent Inflammatory Response
While CF cells naïve to infection show a modestly increased basal level of
pro-inflammatory cytokines, exposure to infection causes an exaggerated
inflammatory response followed by a persistent increased basal secretion level of
these same cytokines. CF primary cell cultures taken from chronically infected
individuals display increase levels of pro-inflammatory cytokines IL-6 and IL-8.
Also, these cells tend to secrete a decreased level of the anti-inflammatory
mediator IL-10, in comparison to healthy controls [27, 28]. BALF from CF airways
recapitulated these findings showing increased levels of TNF-α, IL-1β, IL-6, IL-8,
with very low levels of IL-10 [29]. Even when immortalized epithelial cell lines
with functional CFTR are treated with CFTRinh-172, a potent and specific CFTR
inhibitor, they express increased levels of IL-8 in response to Pa [30]. This basalstate imbalance provides evidence of a prolonged, persistent, and exaggerated
inflammatory state in CF, that directly results from loss of CFTR function [31].

1-2.4 Altered Receptor Signaling and Intracellular Pathways Cause
Inflammation
1-2.4.1 Dysregulation of Pattern Recognition Receptors
Pattern recognition receptors (PRRs) expressed on epithelial cells are the
sentinels of the innate immune system, but these receptors are also expressed
on monocytes, macrophages (Mϕs), lymphocytes and neutrophils [23]. PRRs
include multiple receptor types, including Toll-like receptors (TLRs), nucleotidebinding oligomerization domain family, Fc receptors, and RIG-like receptors.
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Airway epithelial cells primarily employ TLRs, expressing a variety of surface and
intracellular iterations. Evidence shows that in CF, dysregulation of the trafficking,
desensitization, internalization and degradation of PRRs leads to the activation of
pro-inflammatory pathways without resolution [32]. Therefore, these receptors
provide a link between epithelial cells, innate and adaptive immune cells, and
systemic hyperinflammation.

1-2.4.2 NFκB Pathway Drives Inflammation
Acting downstream of PRRs, nuclear factor-kappa B (NFκB), is a pathway
that is also found in all the aforementioned cell lines. TLRs are implicated in the
activation of NFκB, which involves IκB kinases phosphorylating the inhibitory IκB
proteins [33]. Upon activation, NFκB localizes to the nucleus and up-regulates
pro-inflammatory cytokines. In primary cell cultures of CF cells, NFκB shows an
increased nuclear localization in comparison to healthy donor (HD) cells [34].
Further studies show an increase of NFκB proteins in congruence with a
decrease in inhibitory IκB protein and lipopolysaccharide-inducible protein A20.
Human tracheal epithelial cells treated with CFTR inhibitors show an increased
translocation of NFκB, followed by increased secretion of pro-inflammatory
cytokines [35]. As mentioned before, the CF lung environment has increased
basal levels of pro-inflammatory cytokines, such as IL-8 and decreased levels of
IL-10. With respect to NFκB, IL-8 serves to activate the pathway, while IL-10
serves as an inhibitor of the pathway [36]. Thus, the imbalance of these two
cytokines in the CF airway leads to excessive, persistent activation NFκB,
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resulting in the further overexpression of pro-inflammatory cytokines IL-6, IL-8,
TNF-α, and IL-1β [37, 38].

1-2.4.3 Other Pathways that Drive Inflammation
While the NFκB pathway has been well described as dysfunctional in CF,
abnormal lipid metabolism, decreased production of nitric oxide, the misfolded
protein stress response, and increased levels of ceramide are other immune
pathways that are characterized as abnormal in CF [39].

1-2.5 Innate and Adaptive Immunity may Directly Contribute to CF
As evidenced by the “High Salt Hypothesis” and the “Dehydration
Hypothesis”, as well as ex-vivo, in-vitro, and primary cell experiments on naïve
cells, dysfunctional CFTR in epithelial cells directly leads to hyperinflammation.
Yet, cells of the innate and adaptive immune systems, not epithelial cells, have
principally been described as the regulators of inflammation. The discovery that
the promoter of the CFTR gene shared characteristics with housekeeping genes,
inspired research exploring the expression levels of CFTR in non-epithelial cells.
This research found that cells of the innate and adaptive immune systems
express CFTR [40]. The confirmation of significant expression levels of CFTR in
lymphocytes, neutrophils, monocytes, and dendritic cells (DCs) links our
understanding of the cells that regulate inflammation and the implication that
these cells directly cause the hyperinflammation found in CF as a result of CFTR
loss of function.
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1-2.5.1 Neutrophils
1-2.5.1.1 Exaggerated Neutrophil Response
As stated above, CF airway cells produce an abnormal amount of IL-8, a
primary chemokine for attracting neutrophils. Thus, a hallmark of CF lung
disease is increased neutrophil recruitment. Additionally, in CF, neutrophils do
not undergo the usual cycle of recruitment, activation, phagocytosis/bacteria
killing, and apoptosis with clearance, which leads to the accumulation of
neutrophils [31]. As a result, CF lungs are more prone to hyperinflammation,
ineffective bacterial clearance, and tissue damage and lung remodeling.

1-2.5.1.2 Impaired Neutrophil Bacterial Killing
Abnormal accumulation of neutrophils in CF has been shown in the BALF
of naïve airways, airways infected with Pa, and the airways of adults with no
signs of current exacerbations [25-28]. These elevated levels may result from the
decreased effectiveness of bacterial killing. Killing deficiencies result from the
inability of phagolysosomes in neutrophils that lack CFTR to adequately lower pH
[32]. CF neutrophils also display decreased degranulation of antimicrobial
proteins containing secondary and tertiary granules [37]. Impaired bacterial killing
resulting from loss of CFTR function in neutrophils leads to the inability of the CF
lung to clear infection and ultimately resolve inflammation.
-–
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1-2.5.1.3 Neutrophil Elastase is Increased
Neutrophil elastase further compounds the deleterious effects of
deficiencies in neutrophil killing. Accumulation of neutrophils leads to high
concentrations of neutrophil elastase in CF airways. Left unchecked, neutrophil
elastase dismantles gross lung anatomy through the degradation of collagen and
elastin [37]. Also, elevated elastase disrupts the regulation of immune signaling
pathways via the cleavage of plasma membrane receptors and proteins [32].
Clinicians have utilized this knowledge to use neutrophil elastase concentrations
in sputum as a biomarker for decline in lung function in CF patients [41].

1-2.5.1.4 Neutrophils Drive Inflammation with ROS
Neutrophils use the anti-microbial properties of reactive oxygen species
(ROS) when activated in the lung. Due to the accumulation and protracted
presence of neutrophils, ASL fluid collected from CF lungs contains elevated
concentrations of ROS. These levels are further exacerbated by the metabolic
abnormalities in CF cells that reduce their antioxidant capabilities, as well as the
repeated release of DNA by dead neutrophils that ramp up oxidative stress.
Similar to neutrophil elastase, low levels of ROS are protective, but ultimately
become drivers of sustained hyperinflammation in CF lungs due to their
persistent, high concentrations [42]. In conclusion, neutrophils help set in motion
a cycle of inflammation, and their persistent accumulation contributes to the
prolonged, exaggerated state of hyperinflammation in CF lung disease.
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1-2.5.2 Lymphocytes
1-2.5.2.1
IL-17
Response
Lymphocytes Lacking CFTR

is

Dysregulated

in

Certain deadly pathogens like Pseudomonas Aeruginosa and A. fumigatus
trigger the pro-inflammatory IL-17 response – an adaptive response that recruits
neutrophils and encourages phagocytes to uptake and kill these pathogens.
Th17 cells, a specific helper-T cell that secretes IL-17, orchestrate this response.
While initially this response is adaptive, CF patients are unable to clear these
infections, for reasons described earlier, resulting in a sustained IL-17 response
in CF patients. This sustained response is associated with bronchiectasis and
classic airway obstruction disease [43]. The sputum collected from CF patients
shows up-regulation of IL-17 secretion [44], and these results corroborated in
CFTR knockout mouse that showed increased levels of IL-17 in BALF when
challenged with A. fumigatus [39, 45]. An exaggerated Th17 response in
lymphocytes lacking CFTR leads to the pathophysiology of sustained
hyperinflammation and tissue remodeling that leads to obstructive lung disease
in CF.
A deficiency in the enzyme indoleamine 2,3-dioxygenase (IDO), an
enzyme that catabolizes tryptophan, may explain the increase of Th17 cells
found in CF patients. IDO deficiency has been shown to be associated with
patients homozygous for F508del [46]. CFTR knockout mice show correlations
between IDO deficiency and an increase in Th17 cell frequency. As a result, mice
are more susceptible to infection with A. fumigatus. When IDO is replaced in
these mice, they show reduced susceptibility to A. fumigatus infection [46].
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1-2.5.2.2 CF Patients Lack Functioning T-Regulatory
Lymphocytes
Research has also recently begun on identifying defects in lymphocytes
that can be attributed to CFTR loss of function. Studies show that CF patients
may have both defective and overall reduced number of circulating Treg cells
[47]. Tregs express CD4+, CD25+,Foxp3+ surface markers, and as a subset of
CD4+ cells they are responsible for preventing autoimmunity and dampening
down excess inflammation [48]. They also secrete anti-inflammatory cytokines IL10 and TFG-β1. In CF patients colonized with Aspergillus fumigatus (A.
fumigatus), the subset of patients that develop allergic bronchopulmonary
aspergillosis (ABPA) tend to have decreased frequency of Tregs in comparison
to CF patients that are colonized with A. fumigatus but do not develop ABPA [48].
Also in association with lower Treg frequency was the proclivity for these
patients’ cells to exhibit exaggerated Th2 and Th17 responses. Therefore, the
lack of Treg cells helps create the imbalanced environment found in CF lungs
that tends show exaggerated pro-inflammatory IL-8 and IL-17 responses, with
insufficient counterbalancing anti-inflammatory IL-10 responses.

1.3 Macrophages Directly Contribute To CF Pathophysiology: Importance
of Macrophage dysfunction to CF lung disease
1-3.1 Discovery of ‘Phagocytes’
Eli Metchnikoff first characterized the macrophage in the late 19th century,
describing the cells as diverse agents of inflammation and host defense that, free
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of anatomical restrictions, are permitted to circulate throughout the body “eating
to defend”. Thus, the “phagocytosis theory” was born. Drawing on brilliant
scientific intuition, Metchnikoff understood that embryologic development was
rooted in Darwinism. He used “ontogenetic recapitulation to understand
phylogenetic development” [49], recognizing not only that macrophages were
derived from an ancient phylogenetic origin, but also understanding that they
represented an end point of a process of differentiation that was put in motion
from the original embryological cell division [49].

1-3.2 Diverse Roles of Macrophages
These seminal discoveries serve as the foundation for our understanding
of the innate immune system and the diverse roles of macrophages. Today, we
understand that macrophages are more than a specialized agent of innate
immune system responsible only for elimination of pathogens and phagocytosis.
Macrophages serve many essential functions in tissue homeostasis and
development, releasing growth factors and directing tissue-repair through the
sensing of tissue damage [50]. Macrophages also support tissue homeostasis
through removal of apoptotic cells, remodeling of extracellular matrix, and serve
as support cells for principal cells that execute primary tissue function roles, i.e.
alveolar macrophages’ support of alveolar epithelial cells in surfactant
homeostasis through recycling of surfactant [50]. Finally, pathological processes
such as cancer, fibrosis, obesity, and osteoporosis often reappropriate
macrophages plasticity, transforming them into drivers of disease [50].
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1-3.3 Origins of Macrophages
Macrophages have distinct roles depending on functional demand, tissue
location, and homeostatic state of tissues. This diversity in phenotype depends
on the different embryological origin of tissue resident macrophages, deriving
from the yolk sac, fetal liver, and hematopoietic stem cells in the bone marrow
[51, 52]. These macrophage populations are able to remain as distinct
populations due to their capability of continual self-renewal throughout the
lifespan of the organism [53]. Epigenetics and enhancer-mediated geneexpression further distinguish distinct macrophage populations from each other in
a tissue-specific and ontogenetic origin-specific manner.

1-3.4 Process of Differentiation
This background gives macrophages the flexibility to assume a diverse
breadth of phenotypes. Deriving from different embryological backgrounds,
arriving to tissues partially pre-programmed, macrophages undergo a process of
activation, differentiation, and polarization [50]. Tissue-identity signals, functionaldemand signals or a combination of both directs this process through signaling
pathways involving hierarchically organized transcriptional regulators. In the
process of maturation, progenitor cells first undergo activation, assuming a
specific phenotypic endpoint, followed by reversible polarization, and concluding
with stable, irreversible differentiation [50]. Maturation transitions from reversible
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polarization to irreversible differentiation when the signals directing transcriptional
control become more stable and consistent.

1-3.5 Polarization of Macrophages
Throughout this manuscript, the term polarization refers to the process by
which activated macrophages receive regulatory signals that alter their cellular
biology through differential expression of genes, translation of proteins,
regulation of metabolism, and control of signaling pathways. Initially, polarization
was described as the process by which macrophages assume one of two
phenotypes that occupy opposite ends of a bipolar vector: M1 macrophages and
M2 macrophages [52]. This concept was modeled after the dichotomous
lymphocyte system of Th1 and Th2 cells. We now understand that this model
was oversimplified, and as a result we did not appreciate the broad spectrum of
macrophage phenotypes [53]. New descriptions of macrophage polarization
account for the myriad of signals that drive macrophages to become certain
phenotypes through the activation of specific pathways (Fig 1). Therefore, the
original dichotomous polarization model has not been discarded, but instead
expanded. As a result, the original paradigm that described macrophages as M1
or M2 is still used, but now adds further subdivisions for classification that
account for the individual pathways that are activated by specific signals, as well
as the idea that hybrid phenotypes exist [54, 55].
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Figure 1: Polarization of Macrophages: Specific signals determine macrophage
polarization and create a spectrum of phenotypes that expand beyond the
original dichotomous M1 and M2 model.

1-3.5.1 M1 Phenotype
The M1 phenotype describes macrophages that express prototypic
inflammatory responses and markers. The two most common stimuli that lead to
the M1 phenotype are IFN-γ and LPS. IFN-γ activates the IFN-γ receptor that is
formed by the IFNγR-1 and IFNγR-2 chains. Activation of this receptor recruits
JAK1 and JAK2, which in turn recruits STAT1 and then activates the protein
through phosphorylation. Phosphorylated STAT1 translocates to the nucleus
where it is responsible for controlling the gene expression of cytokine receptors,
cell activation markers, and adhesion molecules (Fig. 2). LPS signals TLRs that
activate the MyD88 and TRIF proteins, which in turn activate NF-κB, IRF and AP1. Both IFN-γ and LPS are responsible for the increased expression of pro-
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inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-12, as well as the
decrease in anti-inflammatory cytokine IL-10 [55].

Figure 2: M1 Pathway: LPS and IFN-γ initiate the cascade of signaling that
results in M1 polarization. Activation of INFγR and TLRs eventually lead to the
phosphorylation of STAT1 which translocates to the nucleus, thereby increasing
expression of pro-inflammatory cytokines IL-6, TNF-α, IL-1β, among other genes.
1-3.5.2 M2 Phenotype
The M2 phenotype refers to macrophage phenotypes that are involved in
resolution of inflammation and tissue repair. The most commonly described
cytokine in this subdivision is IL-4, although IL-13, IL-10, and other ligands have
also been characterized [55]. IL-4 activates IL-4 receptor, which activates JAK1
and JAK3. JAK1 and JAK3 then phosphorylate STAT6, which can translocate to
the nucleus upon phosphorylation. STAT 6 mediates the gene expression of anti-
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inflammatory cytokines as well as receptors that mitigate the effects of proinflammatory cytokines [55] (Fig. 3).

Figure 3: M2 Pathway: IL-4 initiates the cascade of signaling that results in M2
polarization. Activation of IL-4R eventually leads to the phosphorylation of
STAT6, which translocates to the nucleus, thereby increasing expression of antiinflammatory cytokines PPARγ, MRC-1, and TGF-β, among other genes.
1-3.6 Macrophages and CF Lung Disease
In 1982, before the CFTR gene had even been characterized,
macrophages were first hypothesized to be involved in the pathogenesis of CF
lung disease [56]. Although the mediators and mechanisms characterized in the
original paper have not been substantiated, evidence is mounting in support of
the conclusion that macrophages directly contribute to the underlying
pathophysiology of CF.
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1-3.6.1 Macrophages Express Functioning CFTR
Monocytes and macrophages must express CFTR in order to establish
that a causal link between monocytes and CF pathogenesis exists. In 1989 the
CFTR gene was identified, and in 1991 Yoshimura et al. first showed that CFTR
mRNA levels in monocytes/macrophages were comparable to levels found in
HeLa epithelial cells [40]. Sorio et al. followed up this finding by discovering
physiologic levels of CFTR protein in monocytes/macrophages, localizing the
protein to the apical surface of monocytes, and showing CFTR functionality when
stimulated with forskolin/IBMX [57].

1-3.6.2 CFTR Defects Directly Affect Macrophage Function
Once the presence of functional CFTR in macrophages was confirmed,
research focused on elucidating the effects of dysfunctional CFTR on
macrophages. In vivo studies of CF alveolar macrophages taken from the BALF
of mice show an exaggerated secretion of pro-inflammatory cytokines IL-1a, KC,
TNF-α, IL-6 when stimulated with LPS in comparison to WT mice. These studies
show that CF macrophages are hyperinflammatory in response to M1 cytokines
[58].
In order to prove that the exaggerated response is intrinsic to
macrophages, and independent of the potentially pro-inflammatory environment
of CF lungs, in vitro studies were performed on macrophages derived from
peripheral blood derived monocytes of CF, heterozygote (HT), and WT mice.
Even after naïve bone marrow-derived cells are cultured in a neutral petri dish for
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10 days, LPS evokes an exaggerated pro-inflammatory response in CF
macrophages in comparison to WT macrophages. These experiments show that
hyperinflammatory secretion of cytokines by CF macrophages appears to be
CFTR dependent, especially when considering that heterozygotes showed an
intermediate phenotype [59].
This work was further supported by experiments performed on mouse
bone marrow chimeras. By first irradiating the bone marrow of WT or CF mice,
and then transplanting either WT or CF bone marrow, four chimeras were
created: WT marrow-WT background animals, WT marrow-CF background
animals, CF marrow-WT background animals, and CF marrow-CF background
animals. The transplantation of CFTR+/+ macrophages into CFTR-/- background
mice significantly dampened the hyperinflammatory secretion of cytokines, and
converse is true as well. Therefore, independent of environment and background,
hyperinflammation in macrophages appears to be intrinsic to CFTR mutations
[59].
This hypothesis is also supported by work done on a conditional knockout
model of CFTR using myeloid-targeted Cre-recombinase LysMCre transgene,
which is exclusively expressed in neutrophils, macrophages and DCs. This
model shows that mice with a conditional CFTR knockout in monocytes have
worse survival outcomes, increased number of neutrophils and macrophages in
BALF that persists 10 days after infection, decreased bacteria killing, and worse
gross lung pathology in comparison to WT cells, even with normal epithelial cells
[60]. In conclusion, while abnormal ion transport in epithelial cells secondary to
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CFTR defects leads to lung disease, lack of CFTR in immune cells also directly
contributes to CF lung disease.

1-3.6.3 Macrophages Exhibit Mixed M1/M2 Phenotype in CF
Once defects in CFTR were believed to directly affect macrophage
function, research examined polarization profiles of human CF macrophages
using cells recovered from the BALF. Initial studies showed that CF
macrophages had elevated levels of pro-inflammatory cytokines TNF-α, IL-1β, IL8, and IL-6 [29] while also expressing decreased levels of the anti-inflammatory
cytokine IL-10 [61] in comparison to HD macrophages. These studies were
supported and enhanced by later work that showed human CF macrophages
recovered from BALF showed increased levels of the anti-inflammatory cytokines
IL-4 and IL-13, in addition to the pro-inflammatory profile described earlier [62].
These studies describe CF macrophages as possessing a mixed M1/M2 profile,
which may be explained interactions between defective CF macrophages and a
complex CF lung environment that simultaneously exhibits pro-inflammatory and
anti-inflammatory characteristics, as evidenced by chronic inflammation and lung
fibrosis.

1-3.6.4 Mechanisms Contributing to Abnormal CF Mϕ Activity
Extensive research of CF macrophages has uncovered numerous altered
mechanisms that may, individually and symbiotically, contribute to abnormal CF
macrophage activity. CF macrophages exhibit dysregulated signal pathway
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regulation due to aberrant lipid raft composition that leads to altered levels and
distribution of cholesterol, sphingolipids, and scaffolding proteins [63-66].
Defective vesicle trafficking, docking, and maturation also affect the spatial and
temporal distribution of immune receptors, which increases intensity and duration
of pro-inflammatory signaling pathways [64].

Defective autophagy leads to

prolonged retention of TLR4, ultimately causing increased activation of the proinflammatory pathways like NF-kB when stimulated with LPS [58]. The NF-kB
pathway is further activated in CF macrophages secondary to dysregulated
nuclear receptors such as PPARγ [67]. Over-activation of the XBP-1 arm of the
unfolded protein response due to mutations in CFTR also leads macrophage
activity [68]. All these disturbances in CF macrophage signaling lead to persistent
hyperinflammation and increased secretion of pro-inflammatory cytokines in
response to external stimuli.
CF macrophages also display defects in phagocytosis and bacteria killing.
Defective chemotaxis affects CF macrophages ability to localize to sites of
infection. Abnormal lipid rafts affect CF macrophage surface membrane’s ability
to properly reorganize into formations necessary for phagocytosis [57].
Furthermore, phagolysosomes exhibit defective maturation capacity, and show
inability to properly kill bacteria resulting from improper regulation of pH and ROS
formation [69, 70]. Finally, macrophages do not produce normal levels of antibacterial molecules [71]. Ultimately, these defects lead to macrophages
underperform the vital functions of bacterial killing and phagocytosis of dead cells
necessary to clear infections and dampen inflammation.
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2. Statement of Purpose

Even though the CFTR gene was identified in 1989 , research to establish
direct links between the gene mutation and the pathophysiology of the disease
still spark controversy. Up until recently, most research has focused on how
defective CFTR disrupts ion transport in airway epithelia cells. Since CFTR gene
expression was identified in bone marrow derived cell lines [56], mounting
evidence supports the assertion that macrophages directly cause CF disease
pathology due to innate defects that result from mutations in CFTR.
Macrophages serve in a variety of roles from supporting tissue development
and homeostasis, to regulating inflammation, to initiating the host immune
response [50]. The process of polarization describes the mechanism through
which macrophages can assume a broad spectrum of phenotypes depending on
tissue localization, functional demand, and embryological origin. Characterization
of macrophage polarization began in the early 1990’s [54, 55]. Modeled after the
dichotomous lymphocyte classification system, macrophages were classified as
either M1 or M2 phenotypes. Under this system, M1 macrophages refer to cells
stimulated by pro-inflammatory cytokines, such as LPS and INF-γ, and initiate
pathways important in killing intracellular pathogens and inflammation. M2
macrophages refer to cells stimulated by anti-inflammatory cytokines, such as IL4 and IL-10, and initiate pathways important for tissue repair and resolution of
inflammation.
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As our view of macrophages has broadened from a specialized immune cell
to a tissue-support cell, so has our understanding of polarization. We now
characterize polarization as a dynamic, fluid process that activates macrophages
into phenotypes represented better by a 360° color wheel than by a bidirectional
vector.
As mentioned earlier, macrophages with defective CFTR show alterations in
numerous vital pathways involved in phagocytosis, bacterial killing, and signal
transduction [45]. Furthermore, polarization profiles of CF macrophages have
exhibited mixed M1-M2 profiles [61, 62]. While descriptive studies have informed
us of the physiological pathways invoked in M1-M2 polarization, these studies
have not been reproduced in human CF macrophages.
The purpose of this study is:
1) To determine the polarization profiles of human CF macrophages in
comparison to HD macrophages upon stimulation with M1 and M2 cytokines.
2) To characterize in CF macrophages the pathways previously implicated in
polarization, and to compare their signaling profiles to those of HD cells.
3) To determine if the mixed phenotype attributed to CF macrophages is
secondary to dysregulated polarization pathways.
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3. Methods

3.1 Chemicals and Reagents
Pseudomonas aeruginosa (Pa) LPS (Sigma-Aldrich) was prepared in
PBS at 100X stock solution and used at a concentration of 100 ng/mL.
Recombinant human INF-γ (ConnStem) was prepared in 0.1% BSA at a 2000x
stock solution and used at a concentration of 20 ng/mL. Recombinant human IL4 (ConnStem) was prepared in 0.1% BSA at 500x stock solution and used at a
concentration of 20 ng/mL. Recombinant human MCSF (ConnStem) was
prepared in RPMI with 10% H2O at 50x stock solution and used at a
concentration of 50 ng/mL.

3.2 Isolation and Culture of Human Peripheral Bone Marrow Derived Mϕs

3.2-1 Recruitment and Subject Profile
Subjects were recruited and consented according to approved IRB protocol.
All CF subjects were recruited from pediatric clinics and were under the age of 18.
No patients were on Kalydeco or Orikambi at time of recruitment. All patients had
moderate to severe mutations (Figure 4).
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Subject #

Sex

Genotype

12

M

ΔF/G542X

23

F

ΔF/G85E

26

F

2789+57A/21841NS

34

M

ΔF/D110H

45

F

ΔF/ΔF

54

M

ΔF/R117H

58

F

ΔF/ΔF

69

M

ΔF/ΔF

78

F

ΔF/Deletion

81

F

ΔF/1444fs

Figure 4. Subject Demographics: All CF subjects were recruited from
pediatric CF clinic.
3-2.2 Isolation
Using 20G needles, ~10 mL of whole blood was drawn from both CF and
HD patients, and collected in tubes containing EDTA. Whole blood was then
mixed in a 1:1 ratio with PBS solution, before being gently pipetted into 15 mL
conical tubes containing Ficoll solution (Histopaque 1077 Sigma H8889) at 25°
C, always maintaining a 2:1 ratio of whole blood-PBS mixture:Ficoll. These tubes
were then centrifuged at 1100 RPMs for 30 minutes, with centrifuge settings set
to “no break” and “half-speed acceleration”. After 30 minutes of density
centrifugation with Ficoll, whole blood separates into buffy coat layers (Fig. 5).
The layer containing the monocytes was located between the serum and Ficoll
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layers, and this layer was exclusively extracted from the 15 mL conical tubes
(69).

Figure 5. Isolation of Monocytes Using Ficoll: Ficoll solution separated whole
blood into buffy coats upon centrifugation. A cloudy layer that rests above the
clear Ficoll layer contains monocytes, and was isolated for culture.
Once extracted, the monocyte layer was washed in 40 mL PBS with 5 mL RPMI
solution containing 50 ng/mL of MCSF, and then centrifuged at 1500 RPMs for
10 minutes with “full acceleration” and “full break” settings. Upon centrifugation,
the supernatant was discarded, the pellet containing immature monocytes was
dissolved in 3 mL of RPMI supplemented with 10% FBS and 50 ng/mL
recombinant human MCSF per 1x10^6 cells, and then the cells were placed into
6 well plates at 3 x 10^6 cells/well.

3-2.3 Culture
Cells were cultured in 6 well plates and stored in incubators at 37°C with
CO2 5%. Cells were carefully monitored each day for changes in the pH of the
media, as indicated by the media changing color from pink to yellow. This change
in pH was a good surrogate for cell activity, and generally indicates that fresh
media should be added to the wells. Cells usually began to attach to the bottom
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of wells at around day 5, at which time cells were passed into a new well to
expand the culture. Cells were cultured until all 6 wells became confluent, at
about 1x10^6 cells/well, which generally took 10-14 days, at which time they
were ready to be treated with cytokines for experiments.

3-2.4 Confirming Macrophage Population
`

In previously studies, after 1-2 weeks, cells were characterized by flow

cytometry (CD14+/CD45+) and the morphology analyzed on cytospin (figure with
FACS data, and mac picture). For our studies we also relied on the knowledge
that gravity dependent centrifugation using Ficoll has been an accepted method
for isolating lymphocyte, platelet, and monocyte populations. Furthermore, the
RPMI media supplemented with MCSF used to culture these cells, only
stimulates the growth of monocyte activation into macrophages, and would not
support the growth of other cell types. Additionally, when looking under the
microscope, platelets and red blood cells (RBCs) could easily be differentiated
from macrophages due to their red color and smaller size. After ~10 days of
culture, cells appeared to settle to the bottom of the wells, with extended
pseudopodia – characteristic of macrophages (Fig. 6), without visual presence of
RBCs or platelets.
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Figure 6. Confirmation of Macrophage Population: Top panel shows confirmation
of monocyte/macrophage population using flow cytometry. Bottom left panel
shows adherent macrophages as visualized under microscope. Bottom right
panel shows macrophages under high-powered magnification with staining.
3-2.4.1 Confirming CFTR Function in Macrophages
Chloride efflux in macrophages was confirmed by measuring the efflux of
N-[ethoxycarbonylmethyl]-6-methoxy-quinolinium bromide (MQAE), a Cl- -specific
fluorescent dye. Under steady state, MQAE dye is up taken by the cell and does
not fluoresce when it is bound to Cl-. As cells are stimulated and secrete Cl-,
MQAE becomes unquenched and begins to emit light. Cl-- efflux was quantified
as the initial change in MQAE fluorescence over time (slope) as the cells
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transitioned from Cl--containing to Cl--free solutions following dye excitation at
354 ± 10 nm & measurement of emitted light at 460 ± 10 nm [72].

3.3 Cytokine treatments
When cells were ready to be treated, media was aspirated and cells were
washed three times with PBS solution. Cells were organized into three treatment
groups: untreated, M1, or M2. Untreated groups had growth media replaced with
RPMI supplemented with 50 ng/mL MCSF. M1 treatment groups had growth
media replaced with RPMI supplemented with 50 ng/mL MCSF, 20 ng/mL INF-γ,
100 ng/mL of LPS. M2 treatment groups had growth media replaced with RPMI
supplemented with 50 ng/mL of MCSF and 20 ng/mL of IL-4. Experiments
prepared for qRT-PCR were treated for 24 hours, experiments for western blot
were treated for 3 hours (Fig 7).

Figure 7. Macrophage Culture and Treatment Protocol: Macrophages were
treated with either M1 cytokines, LPS and INF-γ, or with an M2 cytokine, IL-4.
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3.4 QT-RT-PCR and Expression Analysis
Cells were lysed in triazol (Qiagen), and total RNA was isolated from
1x106 cells using QiagenRNAMini KitsTM (Qiagen), following the manufacturer’s
instructions. Real-time PCR analysis was performed with a Bio-Rad iCycler using
TaqMan technology. Copy number was normalized by 18S and the relative
expression to untreated cells was calculated by ∆∆Ct method. M1 primers used
were IL-6, TNF-α, and IL-1β. M2 primers used were MRC1, TGFβ1, and PPARγ.
All TaqMan primers and probes were purchased from Applied Biosystems (Life
Technology).

3.5 Protein isolation and Western blot
Cells were washed three times with PBS, and total cell lysate was
extracted

using

RIPA

lysis

buffer

(Cell

Signaling)

containing

1mM

phenylmethanesulfonyl fluoride (PMSF) and protease and phosphatase inhibitor
cocktails (Roche Diagnostics). Protein concentration was determined by a
Bradford assay and an equal amount of protein was separated by
electrophoresis on 4-15% Mini PROTEAN Gels (Bio-Rad Laboratories, CA),
transferred to nitrocellulose membrane (Bio-Rad Laboratories, CA), and probed
with primary antibodies using standard procedures.

3-5.1 Western Blot Antibodies
The following antibodies were used: rabbit monoclonal anti-STAT1 –
D1K9Y (1:1000, Cell Signaling), rabbit monoclonal anti-phospho-STAT1 –Tyr701
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-58D6 (1:1000, Cell Signaling), rabbit monoclonal anti-STAT6-D3H4 (1:1000,
Cell Signaling), rabbit polyclonal anti-STAT6-phosphoY (1:1000, Abcam), rabbit
polyclonal anti-AKT (1:1000, Cell Signaling), rabbit monoclonal anti-phosphoAKTSer473-D9EXP (1:2000, Cell Signaling), and rabbit-HRP anti-actin (1:5000,
Santa Cruz). For detection, horseradish peroxidase was conjugated to IgG
secondary antibodies (1:2000, Santa Cruz), followed by visualization using
enhanced chemiluminescence (ECL). The chemiluminescence imaging system
ChemiDoc (Biorad) and the Image lab software (Biorad) were used for image
acquisition and for signal quantification. Protein relative expression is normalized
to β-Actin. Images have been cropped for presentation.

3.6 Statistical Analysis
Statistical analyses were conducted using two-tailed two-sample t-tests or
two-sample unequal variance t-tests. All experiments were performed in
triplicate, unless otherwise indicated. Data are expressed as mean ± standard
deviation. A P value <0.05 was considered statistically significant. Prism 7.0
(GraphPad) was used for all statistical analyses.
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4. Results

4.1 Macrophages Effectively Transport Cl- Via CFTR
The MQAE results show that macrophages have expected efflux of Clupon stimulation with zero-Cl- solution (Fig. 8, left panel). Furthermore, as
expected, CF macrophages do not show efflux of Cl- in a zero-Cl- solution due to
lack of functioning CFTR (Fig. 8, right panel).

Figure 8. MQAE Efflux in Macrophages: The left panel shows adequate efflux of
MQAE upon stimulation with zero-Cl- solution, which represents Cl- efflux via
CFTR. The panel on the right shows defective Cl- efflux in CF macrophages due
to lack of functioning CFTR.

4.2 LPS/INF-γ Stimulated CF Mϕs Exhibit Different Levels of STAT1/pSTAT1
In order to interrogate the pathway involved in M1 polarization, we studied
phosphorylation levels of STAT1 – a protein well described in macrophage
literature as a regulator of signal transduction and an activator of transcription
(49-50). Upon stimulation by LPS and INF-γ, certain cell surface receptors
transduce signals through the phosphorylation of STAT1. Upon phosphorylation,
STAT1 localizes to the nucleus where it up-regulates the transcription of gene’s
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involved in activating inflammation and pathogen killing. (49,50,70). Thus cell
surface signals affect metabolic activity and phenotypic changes in macrophages
through STAT1 signaling. We found that when stimulated with M1 cytokines,
LPS/INF-γ, CF macrophages displayed differential expression of total STAT1
proteins as well as phosphorylated STAT1 (pSTAT1) proteins. CF macrophages
had decreased protein levels of total STAT1 (Fig. 9; Student TTest, n=3, p < .05),
yet increased ratio of pSTAT1 to STAT1 protein levels at 3-hour time course,
(Student TTest, n=3, p < .05), in comparison to HD macrophages (Fig. 9). In CF
macrophages, total STAT1 protein levels were the highest in untreated cells, and
decreased with stimulation by either M1 or M2 cytokines. Finally, as expected,
phosphorylation rates of STAT1 were only significantly elevated when stimulated
with M1 cytokines, and showed an almost lack of protein levels after M2
cytokines stimulation.

Figure 9. Differential Expression of pSTAT1/STAT1 in CF Mϕs: CF macrophages
show elevated ratio of pSTAT1/STAT1 when stimulated with LPS/INFγ after
three hours and lower expression of total STAT1.
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4.3 LPS/INF-γ Stimulated CF Mϕs hyper-express M1 Gene Markers
We studied the downstream effects of STAT1 signaling by using QT-RTPCR to examine the expression level of three M1 markers, IL-6, TNF-α, IL-1β ,
that are regulated by STAT1 [54, 55]. CF and HD macrophages were stimulated
with M1 cytokines for 24 hours before RNA was isolated.

CF macrophages

hyper-expressed all three markers upon stimulation with M1 cytokines, in
comparison to HD cells (Fig. 10; Student TTEST, n=8, p < .05). Unexpectedly,
when stimulated with M1 cytokines, the M2 marker, TGF-β1, exhibited an on
average, modest increase in expression levels with a broad range (0.1-16.0). In
comparison, HD cells always showed down-regulation of these M2 markers upon
stimulation of M1 cytokines (Fig 11).

Figure 10. Stimulation with LPS/INF-γ Leads to Hyperexpression of M1 Markers
in CF Mϕs: This figure is a representative experiment for expression profiles of
HD vs CF Mϕs upon stimulation with M1 cytokines. All M1 markers showed
hyper-expression in CF cells. (Student T-test, n=8, p <.05)
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Figure 11. Up-regulation of M2 Markers with Stimulation of M1 Cytokine by CF
Mϕs: Representative figure showing increased expression of TGF-β1 and PPARγ
by CF cells.
4.4 IL-4 Stimulated CF Mϕs Exhibit Different Levels of pSTAT6/STAT6
In order to interrogate the pathway involved in M2 polarization, we studied
phosphorylation levels of another signal transducer and activator of transcription,
STAT6. Upon phosphorylation, STAT6 localizes to the nucleus where it upregulates the transcription of gene’s involved in activating resolving inflammation
and coordinating tissue repair [54, 55, 73]. Conversely, STAT6 down-regulates
M1 polarization signaling (Fig. 2). We found that when stimulated with the M2
cytokine, IL-4, CF macrophages displayed differential expression of total STAT6
proteins as well as phosphorylated STAT6 (pSTAT6) proteins. CF macrophages
had decreased protein levels of total STAT6, yet increased ratio of pSTAT6 to
STAT6 protein levels at 3-hour time course (Fig. 12, Student TTest, n-=3, P <
.05), in comparison to HD macrophages. Furthermore, in comparison to HD cells,
CF macrophages showed decreased levels of total STAT6 on average in
untreated groups and cells treated with M1 cytokines. Finally, phosphorylation
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rates of STAT1 were only significantly elevated when stimulated with M1
cytokines versus M2 cytokines, as expected (Figure 12).

Figure 12. Differential Expression of pSTAT6/STAT6 in CF Mϕs: CF
macrophages show elevated ratio of pSTAT6/STAT6 when stimulated with IL-4
after three hours and lower expression of total STAT6 (Student TTest, n=3, p <
.05).
4.5 IL-4 Stimulated CF Mϕs Up-regulate Expression of M2 Gene Markers
We studied the downstream effects of STAT6 signaling by using QT-RTPCR to examine the expression level of three M2 markers, MRC, TGFβ1, and
PPARγ, that are regulated by STAT6 (49,50). CF and HD macrophages were
stimulated with M2 cytokines for 24 hours before RNA was isolated.

CF

macrophages expressed higher levels of all TGFβ1 and MRC upon stimulation
with M1 cytokines, in comparison to HD cells (Fig. 13; Student TTEST, n=8, p <
.05). Even more interesting was the unexpected, aberrant increase in expression
of IL-6, a M1 cytokine, that should be down-regulated upon stimulation by IL-4
(Student TTEST, n=8, p < .05). In comparison, HD cells show down-regulation of
these M1 markers upon stimulation of M2 cytokines (Figure 13).
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Figure 13. Stimulation with IL-4 Leads to Hyper-expression of M2 Markers in CF
Mϕs: This figure is a representative experiment for expression profiles of HD vs
CF Mϕs upon stimulation with M2 cytokines. TGFβ1 and MRC showed hyperexpression in CF cells (Student T-test, n=8, p <.05). PPARγ showed increase on
average.
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5. Discussion

Cystic

Fibrosis

pathophysiology

involves

chronic

infection,

hyperinflammation, and obstructive ductal/airway disease. Until recently,
defective CFTR in epithelial cells was thought to be the primary underlying driver
of disease. We now understand that CFTR is expressed in macrophages, and
that macrophages with defective CFTR display abnormal phagocytosis, bacterial
killing, and cell signaling. Furthermore, abnormal macrophage activity has been
shown to persist even in lungs lacking CF disease or in an environment that
lacks signaling from CF epithelial cells [59, 60]. We believe that dysfunctional
CFTR in macrophages leads to intrinsic defects in cell signaling important for
regulating inflammation. Therefore, CF macrophages directly contribute to
hyperinflammation, chronic infection, and ultimately obstructive disease.
Our experiments showing altered regulation of phosphorylation of STAT6
and STAT 1 in CF macrophages support this conclusion that signaling pathways
are affected in CF. CF macrophages exhibit increased phosphorylation rates of
STAT1 and STAT6 in comparison to HD cells, which indicates that they are
unable

to

appropriately

control

activation

pathways.

Furthermore,

CF

macrophages have lower expression levels of total STAT proteins. Untreated CF
cells have the highest expression of total STAT1, and these levels decrease with
stimulation by either M1 or M2 cytokines. This finding may represent an attempt
by cell machinery to down-regulate these pathways, or maybe transcription of
new STAT proteins cannot keep pace with the rate of phosphorylation.

49
Ultimately, the higher ratio of phosphorylated proteins and the decrease in total
protein suggest that the pathways are dysregulated in CF macrophages.
As STAT proteins traffic to the nucleus and affect gene expression when
phosphorylated, the increased ratio of phosphorylated STAT1 and STAT6
proteins may also explain the elevated levels of expression of M1 and M2 genetic
markers in response to M1 and M2 cytokines. We expected macrophages to
show up-regulation of M1 cytokines in response to LPS/INFγ, but the CF
macrophages showed expression levels that were dramatically higher than the
HD cells. This finding is consistent with the hyperinflammatory state found in
patients with CF, and suggests that CF macrophages may be driving persistent
hyperinflammation in CF patients through up-regulation of expression of M1
cytokines.
When stimulated with IL-4, CF macrophages showed a higher expression
level of M2 markers. Another unexpected finding, though, was that M2 markers
were up-regulated in response to M1 cytokines. Based on previous descriptions
of STAT1 and STAT6 regulation of gene expression markers, we would expect
M1 cytokines to only up-regulate expression of M1 markers while downregulating M2 markers. The converse should be true as well. This inability for CF
macrophages to assume one definitive phenotype when receiving stimulation by
either M1 or M2 cytokines implies that the previously observed mixed
phenotypes of alveolar macrophages from BALF result from intrinsic defects that
result from defective CFTR, in addition to the influence from the complex CF lung
environment.
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The intrinsic mixed phenotype of CF macrophages in the context of
dysregulated STAT1 and STAT6 phosphorylation, as well as the different levels
of total protein, suggests that a master regulator may be implicated in the
aberrant signal pathways. Previous research has explored the role AKT and
phosphorylated AKT play on macrophage polarization. AKT has been shown to
act as a master regulator, affecting cell signaling in ways that up-regulate one
pathway while down-regulating opposing pathways [74]. In this way, AKT can be
seen as applying the gas to one pathway, M1 for example, while applying the
breaks to another pathway, M2 for example (Fig. 14). The mixed phenotypes
observed in CF macrophages may result from abnormal regulation of opposing
pathways by a master regulator such as AKT.

Figure 14. AKT Serves as Master Regulator: AKT directs polarization by
inhibiting M1 pathway signaling and enhancing M2 pathway signaling, thus acting
as a master regulator.
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Finally, dysregulated AKT signaling has been exhibited in macrophage
polarization pathways in connection with decreased levels of insulin growth
factor-1 (IGF-1). Studies show that appropriate levels of IGF-1 are required in
order to allow AKT signaling to completely up-regulate the M2 pathway while
down-regulating the M1 pathway [75]. Furthermore, studies have shown
decreased levels of IGF-1 in the serum of CF patients experiencing pulmonary
exacerbations.

These

clinical

findings

might

explain

why

human

CF

macrophages show mixed phenotypes with dysregulated activation pathways,
and could explain a mechanism underlying hyperinflammaiton.
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